Cytosorbents Corp. Stock Prediction
AI-powered sentiment analysis and prediction trends for CTSO, updated each market day.
CTSO AI Sentiment
AI predicts Cytosorbents Corp. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Cytosorbents Corp.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Sector
Exchange
Market Cap
$37,927,230
Cap Tier
Employees
129
Headquarters
PRINCETON, NJ
Listed Since
May 17, 2005
Website
CTSO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CTSO Volatility
Cytosorbents Corp. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
